Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine.
Bazmi HZ, Hammond JL, Cavalcanti SC, Chu CK, Schinazi RF, Mellors JW. Bazmi HZ, et al. Among authors: hammond jl. Antimicrob Agents Chemother. 2000 Jul;44(7):1783-8. doi: 10.1128/AAC.44.7.1783-1788.2000. Antimicrob Agents Chemother. 2000. PMID: 10858331 Free PMC article.
Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance.
Hammond JL, Koontz DL, Bazmi HZ, Beadle JR, Hostetler SE, Kini GD, Aldern KA, Richman DD, Hostetler KY, Mellors JW. Hammond JL, et al. Antimicrob Agents Chemother. 2001 Jun;45(6):1621-8. doi: 10.1128/AAC.45.6.1621-1628.2001. Antimicrob Agents Chemother. 2001. PMID: 11353603 Free PMC article.
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants.
Schinazi RF, Mellors J, Bazmi H, Diamond S, Garber S, Gallagher K, Geleziunas R, Klabe R, Pierce M, Rayner M, Wu JT, Zhang H, Hammond J, Bacheler L, Manion DJ, Otto MJ, Stuyver L, Trainor G, Liotta DC, Erickson-Viitanen S. Schinazi RF, et al. Antimicrob Agents Chemother. 2002 May;46(5):1394-401. doi: 10.1128/AAC.46.5.1394-1401.2002. Antimicrob Agents Chemother. 2002. PMID: 11959574 Free PMC article.
Therapeutics for COVID-19.
Toussi SS, Hammond JL, Gerstenberger BS, Anderson AS. Toussi SS, et al. Among authors: hammond jl. Nat Microbiol. 2023 May;8(5):771-786. doi: 10.1038/s41564-023-01356-4. Epub 2023 May 4. Nat Microbiol. 2023. PMID: 37142688 Review.
Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir.
Ford ES, Simmons W, Karmarkar EN, Yoke LH, Braimah AB, Orozco JJ, Ghiuzeli CM, Barnhill S, Sack CL, Benditt JO, Roychoudhury P, Greninger AL, Shapiro AE, Hammond JL, Rusnak JM, Dolsten M, Boeckh M, Liu C, Cheng GS, Corey L. Ford ES, et al. Among authors: hammond jl. Clin Infect Dis. 2023 Mar 4;76(5):926-929. doi: 10.1093/cid/ciac868. Clin Infect Dis. 2023. PMID: 36326680 Free PMC article.
State of Current Training for Severe Problem Behavior: A Survey.
Colombo RA, Taylor RS, Hammond JL. Colombo RA, et al. Among authors: hammond jl. Behav Anal Pract. 2020 May 6;14(1):11-19. doi: 10.1007/s40617-020-00424-z. eCollection 2021 Mar. Behav Anal Pract. 2020. PMID: 33732574 Free PMC article.
31 results